HomeRCE • ASX
add
Recce Pharmaceuticals Ltd
Previous close
$0.48
Day range
$0.47 - $0.49
Year range
$0.38 - $0.70
Market cap
107.84M AUD
Avg Volume
98.45K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
WSJ
1 hour ago
Stock Market Today: Nasdaq, S&P 500 Fall; Nvidia, Macy's Stocks in Focus —
Live Updates
8.10%
2.60%
0.0021%
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 1.32M | -39.36% |
Operating expense | 5.00M | 109.54% |
Net income | -5.10M | -164.60% |
Net profit margin | -385.34 | -336.35% |
Earnings per share | — | — |
EBITDA | -4.87M | -170.72% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.42M | 182.74% |
Total assets | 6.37M | 149.22% |
Total liabilities | 15.89M | 208.93% |
Total equity | -9.52M | — |
Shares outstanding | 231.61M | — |
Price to book | -9.50 | — |
Return on assets | -191.84% | — |
Return on capital | -1,251.27% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -5.10M | -164.60% |
Cash from operations | -3.25M | -160.57% |
Cash from investing | -827.00 | 99.61% |
Cash from financing | 3.45M | 162.04% |
Net change in cash | 203.31K | 241.60% |
Free cash flow | -3.15M | -178.49% |
About
CEO
Founded
Apr 11, 2007
Website
